BackIntelligent Medicine Acquisition Overview

Intelligent Medicine Acquisition Total Current Liabilities

Intelligent Medicine Acquisition's total current liabilities is $1.1M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.08M
↑ 355.39% YoYΔ $841828.00 vs prior year quarter

Peer average

Loading

Intelligent Medicine Acquisition Total Current Liabilities History

Loading

Intelligent Medicine Acquisition vs. peers: Total Current Liabilities Comparison

Loading

Intelligent Medicine Acquisition Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Intelligent Medicine Acquisition (IQMD) FAQ

As of the most recent data (December 2022), IQMD shows a total current liabilities of $1.1M. That compares with $240K in the prior-year period — up 355.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IQMD's total current liabilities is now $1.1M (was $240K) — a 355.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Intelligent Medicine Acquisition is outperforming or lagging.

Tracking IQMD's total current liabilities over time shows whether Intelligent Medicine Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $240K in the prior-year period — up 355.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Intelligent Medicine Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $1.1M) with ownership activity and broader fundamentals.